mepenzolate has been researched along with Disease in 2 studies
mepenzolic acid: anticholinergic, antispasmodic agent; RN given refers to parent cpd; structure
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RIESE, JA | 1 |
| KLECKNER, MS | 1 |
2 other studies available for mepenzolate and Disease
| Article | Year |
|---|---|
Clinical observations with cantil, a new anticholinergic for colon disorders.
Topics: Benzilates; Cholinergic Antagonists; Colon; Colonic Diseases; Disease; Muscle Relaxants, Central; Pi | 1957 |
Clinical evaluation of a 3-hydroxypiperidine (cantil) in the therapy of intestinal disturbances. A double-blind, controlled study.
Topics: Benzilates; Diarrhea; Disease; Double-Blind Method; Humans; Intestinal Diseases; Intestines; Parasym | 1959 |